Skip to main content
. 2021 Dec 3;12:780201. doi: 10.3389/fmicb.2021.780201

TABLE 1.

Primers used in this study and PCR conditions.

Target Primer name Sequence (5′–3′)a Use Tmb Reference
adeABC P_adeA_F ATTCGGGATCCCTTCATTTGGGTTAAAAGGCTTC Promoter amplification 59.67 This study
P_adeA_R ATTCGGCGGCCGCCATACTGTCCAAACCTAGTGAGTTT 57.02 This study
adeFGH P_adeF_F ATTCGGGATCCCGATACAGGCACATCAATACGA Promoter amplification 58.77 This study
P_adeF_R ATTCGGCGGCCGCAGGTGCTCCTAGTTATTTGGATACC 59.85 This study
adeIJK P_adeI_F ATTCGGGATCCTTGCACGCGTAGGCGG Promoter amplification 60.02 This study
P_adeI_R ATTCGGCGGCCGCGTTCCACCTCGTTTAGATAAAATCTA 58.33 This study
adeRS P_adeR_F ATTCGGGATCCCTTTGAGTCTTGCTACCTCAGCTT Promoter amplification 59.53 This study
P_adeR_R ATTCGGCGGCCGCGATAATCTGGCTATAGAAAGTGCTTC 58.13 This study
pLPV1Z T3 (modified) GCAATTAACCCTCACTAAAGG Constructs confirmation 54.09 Lucidi et al., 2019
RBS CTTAATTTCTCCTCTTTACTTACTT 51.46 This study

aBoldface target of the BamHI enzyme in forward (F) primers and of the NotI enzyme in reverse (R) primers, respectively.

Italics nucleotides indicate a random sequence included to facilitate the action of the enzyme.

bTo calculate Tm, additional nucleotides to facilitate cleavage by restriction enzymes were not included.